Intrinsic Value of S&P & Nasdaq Contact Us

bioAffinity Technologies, Inc. BIAF NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Diagnostics & Research • US • USD

SharesGrow Score
38/100
1/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — BIAF

bioAffinity Technologies, Inc. (BIAF) has a market capitalization of $12.64M and trades at $2.81. The 52-week range is 0.693-23.1.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.3, Earnings Per Share (EPS) of $-8.66, annual revenue of $6.16M.

The stock has a beta of -0.82, operates in the Healthcare sector.

Trading Data
Current Price$2.81
52-Week Range0.693-23.1
Volume558.79K
Avg Volume (30D)8.97M
Market Cap$12.64M
Beta (1Y)-0.82
Company
IPO Date2022-09-01
Employees57
CEOMaria Zannes
CountryUS
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINUS09076W3079
CUSIP09076W307
Income (Latest Year)
Revenue$6.16M
Gross Profit$1.43M
EBITDA$-10.07M
Operating Income$-10.57M
Net Income$-14.91M
EPS$-8.66
EPS Diluted$-8.66
Shares Outstanding$1.72M
Balance Sheet (Latest Year)
Total Assets$10.96M
Current Assets$7.57M
Cash & ST Investments$6.45M
Total Liabilities$3.68M
Total Debt$1.16M
Net Debt$-5.29M
Total Equity$7.28M
Debt / Equity0.16
Valuation Ratios
P/E Ratio-0.3
P/S Ratio2.05
P/B Ratio1.74
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message